Literature DB >> 28711634

Role of epigenetic modulation in cancer stem cell fate.

Abhijeet Deshmukh1, Mudra Binju2, Frank Arfuso1, Philip Newsholme2, Arun Dharmarajan3.   

Abstract

A sub-population of the tumor micro-environment consists of cancer stem cells (CSCs), which are responsible for the initiation and recurrence of cancer. Recently, epigenetic processes such as DNA methylation, histone modification, and chromatin remodeling have been found to be involved in inducing epigenetic factors in CSCs. Most of these processes, such as DNA methylation, generally occur in the genome that is rich in Cytosine-Guanine repeat sequences, also known as CpG islands, which are distributed throughout the human genome. The Polycomb gene (PcG) complex is a chromatin modifier facilitating the maintenance of embryonic and adult stem cells. Recent evidence suggests that the PcG is also involved in maintaining CSC stemness. We have presented various aspects and examples of how epigenetic modulation may drive or promote tumorigenesis and metastasis by alteration of key transcriptomic programs and signaling pathways in CSCs.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Chromatin immunoprecipitation; Chromatin remodeling; DNA methylation; Epigenetics; Histone modification; Polycomb gene; Wnt signaling pathways

Mesh:

Substances:

Year:  2017        PMID: 28711634     DOI: 10.1016/j.biocel.2017.07.003

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

Review 1.  Reviewing cancer's biology: an eclectic approach.

Authors:  Ibrahim Diori Karidio; Senay Hamarat Sanlier
Journal:  J Egypt Natl Canc Inst       Date:  2021-11-01

Review 2.  Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis.

Authors:  Zhishan Wang; Chengfeng Yang
Journal:  Semin Cancer Biol       Date:  2019-01-11       Impact factor: 15.707

3.  MTA3 Represses Cancer Stemness by Targeting the SOX2OT/SOX2 Axis.

Authors:  Liang Du; Lu Wang; Jinfeng Gan; Zhimeng Yao; Wan Lin; Junkuo Li; Yi Guo; Yuping Chen; Fuyou Zhou; Sai-Ching Jim Yeung; Robert P Coppes; Dianzheng Zhang; Hao Zhang
Journal:  iScience       Date:  2019-11-11

4.  Long noncoding RNA MEG3 blocks telomerase activity in human liver cancer stem cells epigenetically.

Authors:  Xiaoxue Jiang; Liyan Wang; Sijie Xie; Yingjie Chen; Shuting Song; Yanan Lu; Dongdong Lu
Journal:  Stem Cell Res Ther       Date:  2020-11-30       Impact factor: 6.832

5.  Environmental Cadmium Exposure Promotes the Development, Progression and Chemoradioresistance of Esophageal Squamous Cell Carcinoma.

Authors:  Jiongyu Chen; Zhangzhu Zhou; Xueqiong Lin; Jiahui Liao; Yujie Zhang; Bingmeng Xie; Yiteng Huang; Lin Peng
Journal:  Front Cell Dev Biol       Date:  2022-02-18

Review 6.  Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.

Authors:  Saeedeh Keyvani-Ghamsari; Khatereh Khorsandi; Azhar Rasul; Muhammad Khatir Zaman
Journal:  Clin Epigenetics       Date:  2021-05-29       Impact factor: 6.551

7.  miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway.

Authors:  Dong-Min Shi; Xin-Yu Bian; Cheng-Dong Qin; Wei-Zhong Wu
Journal:  Onco Targets Ther       Date:  2018-01-26       Impact factor: 4.147

Review 8.  Breast Cancer Stem Cells.

Authors:  Judy S Crabtree; Lucio Miele
Journal:  Biomedicines       Date:  2018-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.